Lung cancer is the most commonly diagnosed cancer and the leading cause of cancer
deaths in both sexes combined. Recent years have seen major advances in the diagnostic …

Objectives To evaluate the efficiency of radiomics model on CT images of intratumoral and
peritumoral lung parenchyma for preoperative prediction of lymph node (LN) metastasis in …

Non-small cell lung cancer (NSCLC) is a heterogeneous disease accounting for
approximately 85% of all lung cancers. Only 17% of patients are diagnosed at an early …

Background Lung adenocarcinoma (LUAD) is the most common type of lung cancer with a
high incidence and increased mortality. CC chemokine receptors were participating in the …

Objectives Estimating the maximum acceptable cost (MAC) per screened individual for low-
dose computed tomography (LDCT) lung cancer (LC) screening, and determining the effect …

Auranofin, an inhibitor of thioredoxin reductase (TrxR), inhibits the growth of a variety of
cancer cells. In the present study, various lung cancer cells were used to investigate the …

Occult micrometastases can be missed by routine pathological analysis. Mapping of the
pulmonary lymphatic system by near-infrared (NIR) fluorescence imaging can identify the …

Background: Nivolumab has been approved in China as second-line treatment for advanced
non-small-cell lung cancer (NSCLC) via weight-based infusion, based on the CheckMate …

Background: Lung adenocarcinoma (LUAD) represents one of the highest incidence rates
worldwide. Hypoxia is a significant biomarker associated with poor prognosis of LUAD …

Lung cancer is the leading cause of cancer deaths in men and women in the United States.
Accurate staging is needed to determine prognosis and devise effective treatment plans …